These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of hepatitic C virus infection after the French 2002 Consensus Conference]. Cacoub P Rev Med Interne; 2002 Nov; 23(11):889-92. PubMed ID: 12481388 [No Abstract] [Full Text] [Related]
23. Hepatitis drug gets approval for coinfection treatment. AIDS Patient Care STDS; 2005 May; 19(5):351. PubMed ID: 15916498 [No Abstract] [Full Text] [Related]
24. Acute exacerbation among chronic hepatitis C patients: tip of the iceberg that deserves more attention. Wong RJ; Cheung RC Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1181-2. PubMed ID: 23735449 [No Abstract] [Full Text] [Related]
26. Interferon for hepatitis C patients with psychiatric disorders. Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920 [No Abstract] [Full Text] [Related]
27. [Protocol for the antiviral therapy of hepatitis C]. Judit G; Gábor H; Béla H; Mihály M; Alajos P; Ferenc S; István T; László T; ; Orv Hetil; 2010 Jan; 151(2):66-72. PubMed ID: 20061235 [No Abstract] [Full Text] [Related]
28. High relapse rate seen at week 72 for patients treated with R1626 combination therapy. Pockros P; Nelson D; Godofsky E; Rodriguez-Torres M; Everson GT; Fried MW; Ghalib R; Harrison S; Nyberg L; Shiffman ML; Chan A; Hill G Hepatology; 2008 Oct; 48(4):1349-50. PubMed ID: 18821613 [No Abstract] [Full Text] [Related]
29. Hepatitis C: Enhancing treatment for hepatitis C among drug users. Grebely J; Dore GJ Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):11-3. PubMed ID: 21119610 [No Abstract] [Full Text] [Related]
30. Second thoughts about secondary analyses. Ferenci P Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903 [No Abstract] [Full Text] [Related]
32. A view to natural killer cells in hepatitis C. Shoukry NH; Pelletier S; Chang KM Gastroenterology; 2011 Oct; 141(4):1144-8. PubMed ID: 21875586 [No Abstract] [Full Text] [Related]
33. [Assessment and monitoring of patients with chronic hepatitis C on antiviral therapy--state of the art in 2003]. Simon K; Szymczak A Pol Arch Med Wewn; 2004 Jul; 112(1):891-8. PubMed ID: 15526854 [No Abstract] [Full Text] [Related]
34. Pegasys-Copegus combination treats both HIV and hepatitis C. AIDS Read; 2004 Apr; 14(4):164. PubMed ID: 15116695 [No Abstract] [Full Text] [Related]
35. Interferon for hepatitis C patients with psychiatric disorders. Rifai MA; Bozorg B; Rosenstein DL Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919 [No Abstract] [Full Text] [Related]
39. Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges? Vogel M; Page E; Nelson M; Rockstroh JK J HIV Ther; 2009 Mar; 14(1):8-12. PubMed ID: 19731559 [No Abstract] [Full Text] [Related]
40. Delaying HCV treatment in HIV-positive patients. Carter M IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]